Shares of leading vaccine producers, such as Pfizer and Moderna, experienced notable drops after Robert F. Kennedy Jr. was ...

Stocks of major drug makers and biotech companies tumbled in the first full day of trading after Donald Trump announced that ...

Within 10 years of Crohn's disease diagnosis, up to 50% of people will require surgery, with ileocaecal or ileocolonic resection being the most common procedure.1 Surgery is not curative and disease ...

Promotes Edward Brennan, MD, FACS to Chief Scientific Officer & Head of R&D ProgramTORONTO and PHILADELPHIA, Nov. 18, 2024 (GLOBE NEWSWIRE) -- (NASDAQ: MDCX TSXV: MDCX) (the “Company”) is pleased to ...

GlaxoSmithKline places its shingles vaccine Shingrix among its top prospects, with peak sales potential of almost $6 billion. Now, Pfizer and BioNTech are joining forces to try to grab a slice of ...

For the past three years, biotechs and pharmas have renamed, rebranded and more in a bid to refresh their corporate appeal. ...

The rumour mill has been grinding away furiously in the last few days, focusing mainly on a possible bid for GlaxoSmithKline (GSK) by Pfizer. The speculation about a deal to create 'PfizerKline ...

The global major depressive disorder (MDD) treatment market is expected to experience steady growth, projected to develop at ...

Healthcare stocks were falling Friday morning after noted anti-vaccine crusader Robert F. Kennedy Jr. was announced as ...

An estimated 828 million adults (420 women, 408 men) had diabetes in 2022, an increase of 630 million since 1990. India (212 ...

GSK is suing Pfizer, claiming Pfizer’s RSV vaccine, Abrysvo, infringes patents for GSK’s Arexvy. Both vaccines target older adults and compete in a market projected to exceed $10 billion by 2030.